Mizuho Forecasts Strong Price Appreciation for UnitedHealth Group (NYSE:UNH) Stock

UnitedHealth Group (NYSE:UNH) had its target price upped by research analysts at Mizuho from $410.00 to $440.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the healthcare conglomerate’s stock. Mizuho’s price objective suggests a potential upside of 13.06% from the company’s previous close.

A number of other brokerages have also recently issued reports on UNH. Barclays lifted their price objective on UnitedHealth Group from $327.00 to $373.00 and gave the company an “overweight” rating in a report on Wednesday, April 22nd. Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target for the company in a report on Wednesday, April 1st. Leerink Partners raised their price objective on shares of UnitedHealth Group from $345.00 to $400.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Morgan Stanley boosted their target price on UnitedHealth Group from $375.00 to $395.00 and gave the stock an “overweight” rating in a report on Wednesday, April 22nd. Finally, HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target for the company in a report on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $385.39.

UnitedHealth Group Stock Down 0.5%

Shares of UNH opened at $389.19 on Wednesday. UnitedHealth Group has a 12 month low of $234.60 and a 12 month high of $404.15. The stock has a market cap of $353.44 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 1.69 and a beta of 0.64. The company has a 50-day moving average price of $320.90 and a two-hundred day moving average price of $318.59. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. During the same period in the prior year, the firm posted $7.20 EPS. UnitedHealth Group’s quarterly revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts predict that UnitedHealth Group will post 18.29 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.28% of the company’s stock.

Institutional Trading of UnitedHealth Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Guerra Advisors Inc acquired a new position in shares of UnitedHealth Group during the third quarter worth about $1,059,000. Money Concepts Capital Corp grew its stake in shares of UnitedHealth Group by 59.1% during the 3rd quarter. Money Concepts Capital Corp now owns 12,380 shares of the healthcare conglomerate’s stock worth $4,275,000 after acquiring an additional 4,600 shares in the last quarter. Phoenix Financial Ltd. boosted its holdings in UnitedHealth Group by 111.5% during the third quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock worth $14,282,000 after purchasing an additional 22,137 shares during the last quarter. Public Sector Pension Investment Board increased its stake in UnitedHealth Group by 43.1% in the 3rd quarter. Public Sector Pension Investment Board now owns 287,132 shares of the healthcare conglomerate’s stock valued at $99,147,000 after buying an additional 86,432 shares during the last quarter. Finally, Compass Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth about $13,691,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Higher Q1 2027 EPS estimate to $6.87 from $6.77, suggesting improved near-term earnings outlook.
• Positive Sentiment: Higher Q3 2027 EPS estimate to $4.57 from $4.27, indicating stronger expectations for later-period profitability.
• Positive Sentiment: Higher Q4 2027 EPS estimate to $3.92 from $3.46, another sign of analyst confidence in future earnings.
• Positive Sentiment: Higher FY2027 EPS estimate to $20.52 from $19.76, and FY2028 EPS estimate to $22.75, supporting a longer-term growth case.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.